Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Fertility and Sterility

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.fertnstert.2017.08.029PMID 28987789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach.

  2017cited by this paper
• Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study.

  2016cited by this paper
• Comparative Genomic Hybridization Selection of Blastocysts for Repeated Implantation Failure Treatment: A Pilot Study

  2014cited by this paper
• Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles.

  2014cited by this paper
• The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening.

  2014cited by this paper
• External validation of anti-Müllerian hormone based prediction of live birth in assisted conception

  2013cited by this paper
• Prediction of Age at Menopause from Assessment of Ovarian Reserve May Be Improved by Using Body Mass Index and Smoking Status

  2013cited by this paper
• The origin and impact of embryonic aneuploidy

  2013cited by this paper
• Array CGH analysis shows that aneuploidy is not related to the number of embryos generated.

  2012cited by this paper
• Aneuploidy Screening for Embryo Selection

  2012cited by this paper
• Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction.

  2011cited by this paper
• Comprehensive molecular cytogenetic analysis of the human blastocyst stage.

  2008cited by this paper
• Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

  2007cited by this paper
• Fertility and ageing.

  2005cited by this paper
• Biological aging and the etiology of aneuploidy

  2005cited by this paper
• Trisomic pregnancy and the oocyte pool.

  2004cited by this paper
• Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

  2004cited by this paper
• Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes

  2003cited by this paper
• Conception to ongoing pregnancy: the 'black box' of early pregnancy loss.

  2002cited by this paper
• Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancy.

  2002cited by this paper
• Increased concentrations of follicle-stimulating hormone in mothers of children with Down's syndrome.

  1999cited by this paper
• Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy.

  1999cited by this paper
• Age-related decline in fertility: a link to degenerative oocytes?

  1997cited by this paper
• Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women.

  1996cited by this paper
• Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women.

  1994cited by this paper
• Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause.

  1992cited by this paper
• Chiasma Frequency and Maternal Age in Mammals

  1968cited by this paper
• On Bone-Setting

  1872cited by this paper

• Low antimüllerian hormone (<1.2 ng/ml) does not impact oocyte quality and IVF/ICSI outcomes in women ≤40 years old.

  2025cites this paper
• The predictive value of anti-Müllerian hormone on embryo quality in PGT-A cycles analysis

  2025cites this paper
• Elective single blastocyst transfer can achieve acceptable clinical pregnancy and live birth rates compared with elective double cleavage-stage embryo transfer in fresh cycles

  2025cites this paper
• Considering minimal clinically important differences (MCIDs) in assisted reproductive technology.

  2025cites this paper
• The influence of male age and sperm parameters on blastulation and euploidy rates.

  2025cites this paper
• Independent predictors and thresholds of in vitro fertilization outcomes in patients with diminished ovarian reserve

  2025cites this paper
• The number of autologous, vitrified mature oocytes needed to obtain three euploid blastocysts increases with age.

  2025cites this paper
• Preimplantation genetic testing for aneuploidy optimizes reproductive outcomes in recurrent reproductive failure: a systematic review

  2024cites this paper
• ‘Age specific variations in ovarian reserves in healthy fertile and infertile women: A cross sectional study

  2024cites this paper
• Effects of ovarian stimulation on embryo euploidy: an analysis of 12 874 oocytes and 3106 blastocysts in cycles with preimplantation genetic testing for monogenic disorders

  2024influential citation
• Minimum number of mature oocytes needed to obtain at least one euploid blastocyst according to female age in In Vitro Fertilization cycles.

  2024cites this paper
• Comparison of miscarriage rates in low prognosis patients according to the POSEIDON criteria.

  2024cites this paper
• Predictive Factors for the Formation of Viable Embryos in Subfertile Patients with Diminished Ovarian Reserve: A Clinical Prediction Study

  2024cites this paper
• Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).

  2024cites this paper
• Factors Influencing the Pregnancy Outcome of Intrauterine Insemination and Follow-up Treatment

  2023cites this paper
• Cumulative live birth rates with autologous oocytes plateau with fewer number of cycles for each year of age > 42

  2023cites this paper
• Anti-Müllerian hormone in female dromedary camel and its association with super-ovulatory response in embryo donors.

  2023cites this paper
• Antimüllerian hormone (AMH) and age as predictors of preimplantation genetic testing for aneuploidies (PGT-A) cycle outcomes and blastocyst quality on day 5 in women undergoing in vitro fertilization (IVF)

  2023cites this paper
• Number of oocytes and IVF outcomes: Real-world evidence.

  2023cites this paper
• The Ethical, Legal, and Social Issues Impacted by Assisted Reproductive Technologies in Croatia

  2023cites this paper
• Fresh embryo transfer after in vitro insemination of fresh vs. cryopreserved anonymous donor oocytes: which has a better live birth rate? A Society for Assisted Reproductive Technology Clinic Outcome Reporting System analysis.

  2022cites this paper
• Association between the number of oocytes and cumulative live birth rate: A systematic review.

  2022cites this paper
• ANTI-MÜLLERIAN HORMONE IS NOT ASSOCIATED WITH EMBRYO PLOIDY IN PATIENTS WITH AND WITHOUT INFERTILITY UNDERGOING IN VITRO FERTILIZATION WITH PREIMPLANTATION GENETIC TESTING.

  2022cites this paper
• The number and rate of euploid blastocysts in women undergoing IVF/ICSI cycles are strongly dependent on ovarian reserve and female age.

  2022cites this paper
• Relationship Between Number of Oocytes Retrieved and Embryo Euploidy Rate in Controlled Ovarian Stimulation Cycles

  2022cites this paper
• In Vitro Fertilisation and Intracytoplasmic Sperm Injection predictive factors: A review of the effect of female age, ovarian reserve, male age, and male factor on IVF/ICSI treatment outcomes

  2022cites this paper
• The Relationship between Ovarian Ultrasound Parameters and Endocrine and Metabolic Indicators in Patients with Ovarian Syndrome

  2022cites this paper
• The relationship between Anti-Mullerian Hormone and ovarian response and fertility outcome in infertile women undergoing assisted reproductive techniques (ART)

  2022cites this paper
• Logistic regression analyses of factors affecting the euploidy of blastocysts undergoing in vitro fertilization and preimplantation genetic testing

  2022cites this paper
• Risk factors related to chromosomal mosaicism in human blastocysts.

  2022cites this paper
• The Impact of Maternal Age on Chromosomal Aneuploidy, Blastocyst Quality, and Pregnancy Outcomes During Intracytoplasmic Sperm Injection Cycles

  2022cites this paper
• The putative roles of FSH and AMH in the regulation of oocyte developmental competence: from fertility prognosis to mechanisms underlying age-related subfertility.

  2021cites this paper
• Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders

  2021cites this paper
• Telomere Length in Idiopathic Recurrent Pregnancy Loss

  2021cites this paper
• Current mechanisms of primordial follicle activation and new strategies for fertility preservation.

  2021cites this paper
• Fertility technologies and how to optimize laboratory performance to support the shortening of time to birth of a healthy singleton: a Delphi consensus

  2021cites this paper
• Fresh and cumulative live birth rates in mild versus conventional stimulation for IVF cycles in poor ovarian responders: a systematic review and meta-analysis

  2021cites this paper
• The potential role of assisted oocyte activation in the management of a POSEIDON group 3 patient with fertilization failure: A case report and literature review.

  2021cites this paper
• Morphokinetic parameters comparison between euploid and aneuploid blastocysts

  2021cites this paper
• Association between decreased ovarian reserve and poor oocyte quality

  2021cites this paper
• Ethnic and Sociocultural Differences in Ovarian Reserve: Age-Specific Anti-Müllerian Hormone Values and Antral Follicle Count for Women of the Arabian Peninsula

  2021cites this paper
• Maternal Antimüllerian Hormone as a Predictor of Euploid Is Independently Associated With Cumulative Live Birth Rates

  2021cites this paper
• Correlation of TP53 (rs1625895), TP73 (rs3765730), MMP9 (rs17576), and MTHFR (rs868014) polymorphisms with low ovarian reserve.

  2021cites this paper
• Ongoing pregnancy and healthy live births following very short ovarian stimulation of incidentally observed big antral follicles in oligoamenorrheic patients with extremely decreased ovarian reserve

  2020cites this paper
• Anti-Müllerian hormone is an independent marker for oocyte survival after vitrification.

  2020cites this paper
• Anti-Mullerian hormone and its predictive value for assessing oocyte quality

  2020cites this paper
• The complex relationship between female age and embryo euploidy.

  2020cites this paper
• Correlation between biochemical, ultrasonographic and demographic parameters with ovarian response to IVF/ICSI treatments in Mexican women

  2020cites this paper
• Live birth rate from euploid blastocysts is not associated with infertility etiology or oocyte source following frozen-thawed embryo transfer (FET): analysis of 4148 cycles reported to SART CORS

  2020cites this paper
• Elevated levels of nitrous dioxide are associated with lower AMH levels: a real-world analysis.

  2020cites this paper
• SAY NO to mild ovarian stimulation for all poor responders: it is time to realize that not all poor responders are the same.

  2020cites this paper
• Exploring the pros and cons of new approaches for gamete cross-border donation based on fresh and vitrified oocytes

  2020cites this paper
• Is there a correlation between paternal age and aneuploidy rate? An analysis of 3,118 embryos derived from young egg donors.

  2020cites this paper
• The role of total chromosomal disomy in human spermatozoa as a predictor of the outcome of pre-implantation genetic screening.

  2020cites this paper
• Higher chromosomal abnormality rate in blastocysts from young patients with idiopathic recurrent pregnancy loss.

  2020cites this paper
• Logistic regression analyses of factors affecting fertility of intrauterine adhesions patients.

  2020cites this paper
• DuoStim: a new strategy proposed for women with poor ovarian response.

  2020cites this paper
• Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection

  2020cites this paper
• Diminished ovarian reserve versus ovarian aging: overlaps and differences

  2019cites this paper
• Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model.

  2019cites this paper
• Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders

  2019cites this paper
• The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists

  2019cites this paper
• Is there an association between oocyte number and embryo quality? A systematic review and meta-analysis.

  2019cites this paper
• Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination

  2019cites this paper
• Anti-Müllerian hormone in association with euploid embryo transfer outcomes.

  2019cites this paper
• Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification

  2019cites this paper
• Do serum androgens influence blastocysts ploidy in karyotypically normal women?

  2019influential citation
• Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes

  2019cites this paper
• Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles

  2019cites this paper
• The incidence of unexpected poor ovarian response in Chinese young women

  2019cites this paper
• A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator

  2019cites this paper
• The cost of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): a counseling tool

  2018cites this paper
• Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay

  2018cites this paper
• Späte Mutterschaft und Aufschub der Familiengründung

  2018cites this paper
• Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).

  2018cites this paper
• Untapped Reserves: Controlling Primordial Follicle Growth Activation.

  2018cites this paper
• Individualized controlled ovarian stimulation in expected poor-responders: an update

  2018cites this paper
• Degree of mosaicism in trophectoderm does not predict pregnancy potential: a corrected analysis of pregnancy outcomes following transfer of mosaic embryos

  2018cites this paper
• Anti-müllerian hormone variability during ovarian stimulation for IVF : A novel approach to predict fertility treatment outcomes

  2018cites this paper
• Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos.

  2018cites this paper
• Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.

  2018cites this paper
• Micro-RNAs involved in cellular proliferation have altered expression profiles in granulosa of young women with diminished ovarian reserve

  2018cites this paper
• Current clinical applications of antimullerian hormone

  2018cites this paper
• New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men.

  2018cites this paper